Evidence map›Paper›PMID 41377676›Full record

ArticleWorld journal of clinical cases2025

Perspectives on monitoring and diagnosis of chemotherapy-induced cardiotoxicity.

Arnold Méndez-Toro

Abstract readLetter
In one paragraph

Article in World journal of clinical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Arnold Méndez-ToroDepartment of Cardiology, Hospital Universitario Nacional de Colombia, Bogota 111321, Bogotá, Colombia. arnold.mendez@hun.edu.co.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study included all patients at risk for chemotherapy-related cardiotoxicity, without exclusions based on the type of cancer, reflecting the institution's epidemiology with a predominance of breast cancer. Myocarditis was not an exclusion; its absence may reflect underdiagnosis. Age, although a known risk factor, showed no significant differences, and no upper chemotherapy dose limits were imposed to better capture real-world scenarios. A typographical error in the patient count was amended to 195. Limitations include its retrospective design, selection bias, and incomplete dose data. A prospective multicenter registry is underway to enhance diagnostic accuracy, include diverse types of cancer, and improve generalizability.

Indexed as

CardiotoxicityChemotherapyEchocardiographyGlobal longitudinal strainMyocarditisRisk assessment

Identifiers

PMID41377676
PMCPMC12687044

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.